FDAFDA recall D-0787-2026 · Aug 19, 2026
Baxter Healthcare Corporation: Cefazolin in Dextrose recall
Quick answer
- Product
- Cefazolin in Dextrose, Injection, USP, 2g / 100mL (20mg / mL) Single-Dose Infusion Bag in 100mL GALAXY Plastic Container, Frozen Premix, Sterile, Rx only, Manufactured by Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-3508-41.
- Brand
- Baxter Healthcare Corporation
- Codes, lots and dates
- Lot # LD175708, Exp Date: 14-Feb-2027.
- Hazard
- Presence of Particulate Matter
- Distribution
- US Nationwide.
- Quantity
- 19,032 bags
- Recall date
- Aug 19, 2026
- Agency
- U.S. Food and Drug Administration (FDA) enforcement report
- Recall number
- D-0787-2026
Recall found
Product
Cefazolin in Dextrose, Injection, USP, 2g / 100mL (20mg / mL) Single-Dose Infusion Bag in 100mL GALAXY Plastic Container, Frozen Premix, Sterile, Rx only, Manufactured by Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-3508-41.
Reason for recall
Presence of Particulate Matter
What to do
FDA enforcement reports don't include consumer instructions. Check the codes below against your packaging. If this is a medicine or device you use, talk to your pharmacist or doctor before you stop or change anything, and contact the company or FDA for what to do with the product.
| Quantity | 19,032 bags |
|---|---|
| Codes, lots and dates | Lot # LD175708, Exp Date: 14-Feb-2027. |
| Distribution | US Nationwide. |
| Recall date | Aug 19, 2026 |
| Class | Class I |
| Agency ID | D-0787-2026 |
| Official notice | U.S. Food and Drug Administration (FDA) enforcement report |
| Data as of, last checked | Nov 21, 2026, 3:48 PM EST |
Recall details
- FDA classification
- Class I: FDA's most serious class, where use of or exposure to the product may cause serious health problems or death.
- Status
- Ongoing
- Codes, lots and dates
- Lot # LD175708, Exp Date: 14-Feb-2027.
- Quantity
- 19,032 bags
- Distribution
- US Nationwide.
- Recalling firm
- Baxter Healthcare Corporation, Deerfield, IL
- Voluntary or mandated
- Voluntary: Firm initiated
- Recall started
- 2026-07-24
Source: openFDA enforcement record D-0787-2026 · search recall number D-0787-2026 in FDA's Enforcement Report.
Copied from the agency record without changes. Data as of Nov 21, 2026, 3:48 PM EST. The agency notice is the final word.
FAQ
What was recalled?
Product: Cefazolin in Dextrose, Injection, USP, 2g / 100mL (20mg / mL) Single-Dose Infusion Bag in 100mL GALAXY Plastic Container, Frozen Premix, Sterile, Rx only, Manufactured by Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-3508-41. Brand: Baxter Healthcare Corporation Codes, lots and dates: Lot # LD175708, Exp Date: 14-Feb-2027.
What is the hazard?
Presence of Particulate Matter
How do I check if mine is affected?
Codes, lots and dates: Lot # LD175708, Exp Date: 14-Feb-2027.
Where was it distributed?
US Nationwide.
Related recalls
- Baxter Healthcare Corporation: TruSystem 7500 surgical table recall
- Baxter Healthcare Corporation: Mobile column TruSystem 7500 U recall
- Baxter Healthcare Corporation: Operating Table TruSystem 7000 U recall
- Baxter Healthcare Corporation: TruSystem 7000 U Operating Table (dV) recall
- Baxter Healthcare Corporation: Operating table column TS7500 MOBIUS recall
- Baxter Healthcare Corporation: Operating Table TruSystem 7000 U (dV) recall
